Sensenig Bethany 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Aug 21, 2023
Insider Transaction Report
Form 4
Sensenig Bethany
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2023-08-17+24,153→ 24,153 totalExercise: $30.22Exp: 2033-08-17→ Common Stock (24,153 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on August 17, 2024.